首页 | 本学科首页   官方微博 | 高级检索  
     


Symptomatic Combined Homozygous Factor XII Deficiency and Heterozygous Factor V Leiden
Authors:Girolami  A.  Simioni  P.  Scarano  L.  Girolami  B.  Zerbinati  P.
Affiliation:(1) Department of Adult Oncology, Dana-Farber Cancer Institute, USA;(2) Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, USA;(3) Pentucket Medical Associates, Newburyport;(4) Department of Biostatistics, Dana-Farber Cancer Institute, USA;(5) Department of Nuclear Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Abstract:A family with a combined deficiency of factor XII and factor V Leiden is presented. The proposita is a 72-year-old who showed a mild to moderate thrombotic tendency characterized by two episodes of deep venous thrombosis and superficial phlebitis between the age of 50 and 71. She was shown to be carrier of homozygous factor XII deficiency and heterozygous FV Leiden mutation. A sister of the proposita showed the same pattern but remained asymptomatic. Other family members showed either isolated heterozygous factor XII deficiency or combined heterozygous factor XII deficiency and heterozygous FV Leiden mutation but were all asymptomatic. These data lend support to those who maintain that FV Leiden is a mild genetic determinant for thrombosis. The role of FXII deficiency as an additional risk factor remains questionable.
Keywords:factor XII deficiency  APC resistance  combined defects
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号